Braden Higgs

Royal Adelaide Hospital — Australia

Medicine · Health Sciences

11h-index764citations44works11.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Diagnosis and Treatment(15), Advanced Radiotherapy Techniques(9), Renal cell carcinoma treatment(9), Prostate Cancer Treatment and Research(9), Lung Cancer Diagnosis and Treatment(6)

Publications44 total

Efficacy of SABR in Uncommon Subtypes of Primary Kidney Cancer: An Analysis From the International Radiosurgery Oncology Consortium of the Kidney
International Journal of Radiation Oncology*Biology*Physics·2025· 4 cited
Ultra-Hypofractionated Stereotactic Ablative Body Radiotherapy (SABR) for Primary Renal Cell Carcinoma: Pooled Outcomes from the FASTRACK and FASTRACK II Clinical Trials
International Journal of Radiation Oncology*Biology*Physics·2025Open Access
Treatment variations in localised prostate cancer in Australia and New Zealand: a registry study
British Journal of Urology·2025Open Access
Socioeconomic and Geographic Disparities in Anorectal and Urinary Procedures Following Radiotherapy for Prostate Cancer
Cancer Medicine·2025· 1 citedOpen Access
SABR Versus Radiofrequency Ablation and Cryoablation for Primary Renal Cell Carcinoma: An Economic Evaluation of the FASTRACK II Trial
International Journal of Radiation Oncology*Biology*Physics·2025· 1 cited
Post-prostatectomy radiation therapy: Updated guidelines of the Australian and New Zealand Radiation Oncology Genito-Urinary Group (FROGG)
Radiotherapy and Oncology·2024· 4 cited
Comparing post-treatment urinary and colorectal procedures in prostate cancer patients using population-based linked data
International Urology and Nephrology·2024· 2 cited
235: Dose-effect relationship after SABR for primary renal cell carcinoma: FASTRACK II (NCT02613819)
Radiotherapy and Oncology·2024
Dose-Effect Relationship of Kidney Function After SABR for Primary Renal Cell Carcinoma: TROG 15.03 FASTRACK II
International Journal of Radiation Oncology*Biology*Physics·2024· 11 cited
Stereotactic ablative body radiotherapy for primary kidney cancer (TROG 15.03 FASTRACK II): a non-randomised phase 2 trial
The Lancet Oncology·2024· 93 cited
Medication-based Comorbidity Measures and Prostate Cancer Treatment Selection
Clinical Genitourinary Cancer·2024· 9 citedOpen Access
Risk of secondary malignancy following radiation therapy for prostate cancer
Scientific Reports·2023· 19 citedOpen Access
Reporting Real-World Data on Prostate Cancer Treatment Outcomes to Consumers: The Prostate Cancer Report Card
European Journal of Cancer Care·2023· 6 citedOpen Access
TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II)
International Journal of Radiation Oncology*Biology*Physics·2023· 12 citedOpen Access
Clinical and functional outcomes for risk‐appropriate treatments for prostate cancer
BJUI Compass·2023· 11 citedOpen Access
Patterns of practice regarding use of radiation therapy following radical prostatectomy: A survey of Radiation Oncologists and Urologists in Australia and New Zealand
Journal of Medical Imaging and Radiation Oncology·2023Open Access
Long-Term Outcomes of TROG 13.01 SAFRON II Randomized Trial of Single- Versus Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases
Journal of Clinical Oncology·2023· 21 citedOpen Access
OC-0610 Long-term outcomes of TROG13.01 SAFRON II: Single vs multi-fraction SABR for oligometastases to lung
Radiotherapy and Oncology·2023
To leave, or not to leave? Management of a thyroglossal duct cyst carcinoma
2022Open Access
Patient-reported functional outcome measures and treatment choice for prostate cancer
BMC Urology·2022· 15 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

David Pryor(14), Shankar Siva(13), Nicholas Hardcastle(12), Tomas Kron(11), Mathias Bressel(9), Mark Sidhom(9), Rebecca Montgomery(9), Michael O’Callaghan(8), Jarad Martin(7), Tenaw Yimer Tiruye(7), Kerri Beckmann(7), Eric Yeoh(7), Ben Vanneste(6), Jeremy Ruben(6), Farshad Foroudi(6), Richard De Abreu Lourenço(6), Marketa Skala(6), Giuseppe Sasso(6), Kim Moretti(6), Alex Jay(6)